Investigates RVF exposure in camels and horses, revealing significant seroprevalence and risk factors.
Rift Valley Fever (RVF) is a neglected vector-borne zoonotic disease of significant veterinary and public health concern in Sub-Saharan Africa. This study investigated the seroprevalence of Rift Valley Fever Virus (RVFV) exposure and associated risk factors among camels and horses marketed in northern Nigeria. A total of 1117 animals were sampled, comprising camels (812) and horses (305), across three major livestock markets (Maigatari, Maiduguri, and Illela). The overall seroprevalence was 18.8% (95% CI: 16.6–21.2%), with a striking six-fold disparity: camels showed a prevalence of 24.4% (95% CI: 21.6–27.4%), while horses exhibited only 3.9% (95% CI: 2.1–7.0%). Significant geographic clustering was observed, with Illela camels recording the highest prevalence (34.8%) compared to those in Maigatari (20.3%) and Maiduguri (20.2%). There were no significant associations with age or sex among camels. However, in horses, females were significantly more likely to test positive than males (OR = 0.27, 95% CI: 0.07–0.97). These findings demonstrate endemic RVFV circulation in Nigerian livestock, highlighting species- and location-specific differences, and underscore the zoonotic risks within regional and transboundary livestock trade networks.
No takes yet. Share an insight, caveat, or question.
Ehizibolo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: